# Noraxon USA, Inc. – FDA Inspection, Nov 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/noraxon-usa-inc/6962d3d8-06f0-4a5d-8ba6-875636f2be2c
Source feed: FDA_Inspections

> FDA inspection 1224841 of Noraxon USA, Inc., November 30, 2023. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 820. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224841
- Company Name: Noraxon USA, Inc.
- Inspection Date: 2023-11-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Compliance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 1

## Related Documents

- [FDA Inspection 1065807 - 2018-09-11](https://www.keypedia.com/records/fda_inspections/noraxon-usa-inc/5835c144-cd22-4d1c-bcd5-f2068c7e974b)
- FDA Inspection 884760 - 2014-06-24
- FDA Inspection 751301 - 2011-10-27

## Related Officers

- [Company Rep](https://www.keypedia.com/people/charles-l-larson/4232255d-bfd6-4616-a854-c801e4c23e1c)

Company: https://www.keypedia.com/companies/noraxon-usa-inc/a3c2a806-a940-4a37-920d-b9e31915e7ba

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7